British Heart Foundation to Provide $1.7M for Genetic Screening of Familial Hypercholesterolaemia | GenomeWeb

NEW YORK (GenomeWeb) – The British Heart Foundation said today it is funding more than £1 million ($1.7 million) to a genetic testing program for familial hypercholesterolaemia, a condition that can shorten a patient's life by 20 to 30 years if left untreated.

The program being funded by BHF will pay for nurses to screen patients and their family members for the condition. It also will go toward extending such screening services to eight NHS Trusts across England and Scotland, BHF said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.